Mairead Nayager - Haleon Plc Chief Officer
HLNCF Stock | USD 5.05 0.08 1.61% |
Insider
Mairead Nayager is Chief Officer of Haleon plc
Age | 48 |
Phone | 44 1932 822000 |
Web | https://www.haleon.com |
Similar Executives
Showing other executives | INSIDER Age | ||
Haruhiko Hirate | Takeda Pharmaceutical Co | 68 | |
Ian Clark | Takeda Pharmaceutical Co | 59 | |
Melissa Trombetta | Viatris | N/A | |
Pr Hazum | Painreform | N/A | |
Scott Ferguson | Elanco Animal Health | 46 | |
Sanjeev Sethi | Viatris | 57 | |
David Bayles | Viatris | N/A | |
Salvatore Alesci | Takeda Pharmaceutical Co | N/A | |
Masami Iijima | Takeda Pharmaceutical Co | 70 | |
Racquel Mason | Elanco Animal Health | 50 | |
R Hoover | Elanco Animal Health | 75 | |
J McFarland | Zoetis Inc | 61 | |
Emiko Higashi | Takeda Pharmaceutical Co | 61 | |
Keith Katkin | Emergent Biosolutions | 48 | |
William Price | Zoetis Inc | N/A | |
Christopher Quesenberry | Evoke Pharma | N/A | |
Gabriele Ricci | Takeda Pharmaceutical Co | 47 | |
Shawn McKee | Elanco Animal Health | N/A | |
Robert Polzer | Zoetis Inc | 55 | |
Marcela Kirberger | Elanco Animal Health | 57 | |
Olivier Bohuon | Takeda Pharmaceutical Co | 61 |
Haleon plc Leadership Team
Elected by the shareholders, the Haleon Plc's board of directors comprises two types of representatives: Haleon Plc inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Haleon. The board's role is to monitor Haleon Plc's management team and ensure that shareholders' interests are well served. Haleon Plc's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Haleon Plc's outside directors are responsible for providing unbiased perspectives on the board's policies.
Amy Landucci, Head Technology | ||
Tamara Rogers, Chief Officer | ||
Jooyong Lee, Head CEO | ||
Mairead Nayager, Chief Officer | ||
Brian McNamara, CEO Director | ||
Bjarne Tellmann, G Counsel | ||
Teri Lyng, Head Sustainability | ||
Bart Derde, Head Chain | ||
Filippo Lanzi, Head LatAm | ||
Tobias Hestler, CFO Director |
Haleon Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Haleon Plc a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Profit Margin | 0.13 % | |||
Operating Margin | 0.20 % | |||
Current Valuation | 46.45 B | |||
Shares Outstanding | 9.23 B | |||
Shares Owned By Insiders | 38.54 % | |||
Shares Owned By Institutions | 26.57 % | |||
Price To Earning | 17.50 X | |||
Price To Book | 1.05 X | |||
Price To Sales | 3.41 X | |||
Revenue | 9.54 B |
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in Haleon Pink Sheet
When determining whether Haleon plc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Haleon Plc's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Haleon Plc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Haleon Plc Stock:Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Haleon plc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. For more detail on how to invest in Haleon Pink Sheet please use our How to Invest in Haleon Plc guide.You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.